Molecular Signals Involved in Ocular Neovascularization
Molecular Signals Involved in Ocular Neovascularization
批准号:
6622273
负责人:
Peter A Campochiaro
金额:
$28.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2005-12-31
关键词:
Adenoviridae angiogenesis angiopoietins biological signal transduction capillary bed gene expression genetic promoter element genetically modified animals hypoxia inducible factor 1 insulinlike growth factor ischemia laboratory mouse model design /development pathologic process retina circulation retina disorder retinal ganglion retinal pigment epithelium tetracyclines transcription factor transfection /expression vector vascular endothelial growth factors visual photoreceptor vitreous body
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (From the Applicant's Abstract): The plan of this proposal is to
study interactions between factors that have been implicated in ocular
neovascularization-vascular endothelial growth factor (VEGF), hypoxia-inducible
factor-1 (HIF-1), angiopoietin 2 (Ang2), and insulin-like growth factor
(IGF-1). The plan is to use both transgenic and gene transfer approaches to
test the following hypotheses: 1) Increased expression of VEGF in the inner
retina will result in retinal neovascularization from the deep capillary bed
but not the superficial capillaries as occurs in ischemic retinopathies. 2)
Increased expression of HIF-1alpha will more closely mimic ishemic retinopathy
because it upregulates other factors in addition to VEGF. 3) Increased
production of IGF-1 in the inner retina will not be sufficient to produce
retinal neovascularization, but will enhance the effects of VEGF. 4) Increased
expression of VEGF in retinal pigment epithelial cells (RPE) is sufficient to
cause choroidal neovascularization. 5) Increased expression of Ang2 in the
retina causes regression of neovascularization, while coexpression of Ang2 and
VEGF promotes neovascularization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
-
批准号:10333382
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2022
-
负责人:Peter A Campochiaro
-
依托单位:
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
-
批准号:10593947
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2022
-
负责人:Peter A Campochiaro
-
依托单位:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
-
批准号:10557124
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
A novel hypotonic gelling eye drop for topical treatment of retinal degenerative diseases
-
批准号:10549354
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
A novel hypotonic gelling eye drop for topical treatment of retinal degenerative diseases
-
批准号:10326840
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
-
批准号:10093050
-
项目类别:
-
资助金额:$58.1万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
Integrin-binding Peptide for Ocular Neovascularization and Macular Edema: Molecular Mechanism of Action
-
批准号:10361561
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2019
-
负责人:Peter A Campochiaro
-
依托单位:
Sustained Suprachoroidal Delivery of Therapeutic Peptidesfor Ocular Diseases
-
批准号:9317491
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2016
-
负责人:Peter A Campochiaro
-
依托单位:
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye
-
批准号:8964295
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2015
-
负责人:Peter A Campochiaro
-
依托单位:
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye
-
批准号:9256464
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2015
-
负责人:Peter A Campochiaro
-
依托单位:
Novel Biodegradable Injectable Rod for Improved AMD Therapy
-
批准号:8647445
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2014
-
负责人:Peter A Campochiaro
-
依托单位:
RETINAL NEOVASCULARIZATION IN DIABETIC RETINOPATHY
-
批准号:6342681
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
RETINAL NEOVASCULARIZATION IN DIABETIC RETINOPATHY
-
批准号:2761264
-
项目类别:
-
资助金额:$27.38万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6721137
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6840788
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7211882
-
项目类别:
-
资助金额:$40.97万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
New Treatments of Ocular Neovascularization and Macular Edema
-
批准号:8441484
-
项目类别:
-
资助金额:$38.48万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6444529
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7587922
-
项目类别:
-
资助金额:$39.4万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7415013
-
项目类别:
-
资助金额:$38.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
国内基金
海外基金
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位: